Literature DB >> 19727276

Obstructive sleep apnea, hypoxia, and metabolic syndrome in psychiatric and nonpsychiatric settings.

Atmaram Yarlagadda1, Shaifali Kaushik, Anita H Clayton.   

Abstract

Obesity continues to be a serious cause of morbidity and mortality globally and particularly in North America. Primary manifestations of obesity include obstructive sleep apnea (OSA) and depression associated with a decrease in immune defense mechanisms, possibly related to increased cytokine levels. Secondary manisfestations of obesity possibly result from a cascade of events and include insulin resistance/ hyperglycemia, hyperlipidemia, and hypertension-all of which comprise metabolic syndrome. This paper reviews sleep disturbances in general and OSA in psychiatric patients, particularly those who are obese.

Entities:  

Keywords:  hypoxia; metabolic syndrome; obstructive sleep apna; psychiatric illness

Year:  2008        PMID: 19727276      PMCID: PMC2695736     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  19 in total

1.  Electroencephalographic sleep correlates of episode and vulnerability to recurrence in depression.

Authors:  D J Buysse; E Frank; K K Lowe; C R Cherry; D J Kupfer
Journal:  Biol Psychiatry       Date:  1997-02-15       Impact factor: 13.382

Review 2.  Sleep and depression--results from psychobiological studies: an overview.

Authors:  D Riemann; M Berger; U Voderholzer
Journal:  Biol Psychol       Date:  2001 Jul-Aug       Impact factor: 3.251

Review 3.  Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes.

Authors:  Karine Spiegel; Kristen Knutson; Rachel Leproult; Esra Tasali; Eve Van Cauter
Journal:  J Appl Physiol (1985)       Date:  2005-11

4.  Prevalence of symptoms and risk of sleep apnea in primary care.

Authors:  Nikolaus C Netzer; Josef J Hoegel; Daniel Loube; Cordula M Netzer; Birgit Hay; Rudolfo Alvarez-Sala; Kingman P Strohl
Journal:  Chest       Date:  2003-10       Impact factor: 9.410

5.  Relationship of metabolic syndrome and obstructive sleep apnea.

Authors:  James M Parish; Terrence Adam; Lynda Facchiano
Journal:  J Clin Sleep Med       Date:  2007-08-15       Impact factor: 4.062

Review 6.  Clinical diagnosis and misdiagnosis of sleep disorders.

Authors:  G Stores
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-12       Impact factor: 10.154

7.  Prevalence of the metabolic syndrome in middle-aged men and women.

Authors:  Raquel Villegas; Ivan J Perry; Don Creagh; Rita Hinchion; Domhnall O'Halloran
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112

Review 8.  Obstructive sleep apnea: implications for cardiac and vascular disease.

Authors:  Abu S M Shamsuzzaman; Bernard J Gersh; Virend K Somers
Journal:  JAMA       Date:  2003-10-08       Impact factor: 56.272

9.  Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndrome.

Authors:  Alex Sassani; Larry J Findley; Meir Kryger; Eric Goldlust; Charles George; Terence M Davidson
Journal:  Sleep       Date:  2004-05-01       Impact factor: 5.849

10.  Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study.

Authors:  Bjørn Hildrum; Arnstein Mykletun; Torstein Hole; Kristian Midthjell; Alv A Dahl
Journal:  BMC Public Health       Date:  2007-08-29       Impact factor: 3.295

View more
  2 in total

Review 1.  Interventions to Address Medical Conditions and Health-Risk Behaviors Among Persons With Serious Mental Illness: A Comprehensive Review.

Authors:  Emma E McGinty; Julia Baller; Susan T Azrin; Denise Juliano-Bult; Gail L Daumit
Journal:  Schizophr Bull       Date:  2015-07-28       Impact factor: 9.306

Review 2.  Strange Bedfellows: Nuclear Factor, Erythroid 2-Like 2 (Nrf2) and Hypoxia-Inducible Factor 1 (HIF-1) in Tumor Hypoxia.

Authors:  Rachel K Toth; Noel A Warfel
Journal:  Antioxidants (Basel)       Date:  2017-04-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.